Johnson BE - Search Results

1

RECIST 1.1 in NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors: comparison with RECIST 1.0.

Nishino M, Cardarella S, Jackman DM, Ramaiya NH, Rabin MS, Hatabu H, Jänne PA, Johnson BE. Nishino M, et al. Among authors: johnson be. AJR Am J Roentgenol. 2013 Jul;201(1):W64-71. doi: 10.2214/AJR.12.9668. AJR Am J Roentgenol. 2013. PMID: 23789698 Free PMC article.

2

Lung cancer presenting with solitary bone metastases. Case 2: acrometastasis as an initial presentation of non-small-cell lung carcinoma.

Jänne PA, Datta MW, Johnson BE. Jänne PA, et al. Among authors: johnson be. J Clin Oncol. 1999 Sep;17(9):2998-3001. doi: 10.1200/JCO.1999.17.9.2998. J Clin Oncol. 1999. PMID: 10561378 No abstract available.

3

Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy.

Jänne PA, Rodriguez-Thompson D, Metcalf DR, Swanson SJ, Greisman HA, Wilkins-Haug L, Johnson BE. Jänne PA, et al. Among authors: johnson be. Oncology. 2001;61(3):175-83. doi: 10.1159/000055371. Oncology. 2001. PMID: 11574771 Review.

4

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.

Jänne PA, Taffaro ML, Salgia R, Johnson BE. Jänne PA, et al. Among authors: johnson be. Cancer Res. 2002 Sep 15;62(18):5242-7. Cancer Res. 2002. PMID: 12234991

5

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

Jänne PA, Freidlin B, Saxman S, Johnson DH, Livingston RB, Shepherd FA, Johnson BE. Jänne PA, et al. Among authors: johnson be, johnson dh. Cancer. 2002 Oct 1;95(7):1528-38. doi: 10.1002/cncr.10841. Cancer. 2002. PMID: 12237922 Free article.

6

Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study.

Wirth LJ, Lucca J, Ostler P, Fidias P, Lynch C, Jänne PA, Herbst RS, Johnson BE, Sugarbaker DJ, Mathisen DJ, Lukanich JM, Choi NC, Berman SM, Skarin AT. Wirth LJ, et al. Among authors: johnson be. Clin Cancer Res. 2003 May;9(5):1698-704. Clin Cancer Res. 2003. PMID: 12738723 Clinical Trial.

7

Prospective study of the airways and pulmonary parenchyma of patients at risk for a second lung cancer.

Means-Markwell M, Linnoila RI, Williams J, Jänne PA, Kaye F, O'Neil K, Johnson BE. Means-Markwell M, et al. Among authors: johnson be. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5915-21. Clin Cancer Res. 2003. PMID: 14676115

8

High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines.

Jänne PA, Li C, Zhao X, Girard L, Chen TH, Minna J, Christiani DC, Johnson BE, Meyerson M. Jänne PA, et al. Among authors: johnson be. Oncogene. 2004 Apr 8;23(15):2716-26. doi: 10.1038/sj.onc.1207329. Oncogene. 2004. PMID: 15048096

9

Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy.

Wirth LJ, Carter MR, Jänne PA, Johnson BE. Wirth LJ, et al. Among authors: johnson be. Lung Cancer. 2004 May;44(2):213-20. doi: 10.1016/j.lungcan.2003.11.016. Lung Cancer. 2004. PMID: 15084386

10

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study.

Jänne PA, Gurubhagavatula S, Yeap BY, Lucca J, Ostler P, Skarin AT, Fidias P, Lynch TJ, Johnson BE. Jänne PA, et al. Among authors: johnson be. Lung Cancer. 2004 May;44(2):221-30. doi: 10.1016/j.lungcan.2003.12.014. Lung Cancer. 2004. PMID: 15084387 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

587 results

Search Page

Filters